Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaxing Pan

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|September 16, 2023
Self-Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic CancerJiaxing Pan, Yi Lai, Shunan Zhang, et al.
Advanced Drug Delivery Reviews|June 1, 2025
Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumorsPing Zhang, Jiaxing Pan, Shutong Lin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 7, 2022
Self-Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck CancerYun Zhu, Shunan Zhang, Yi Lai, et al.
Angewandte Chemie (International Ed. in English)|April 26, 2025
De Novo Design of Structure-Tunable Multivalent Targeting Chimeras for Tumor-Targeted PD-L1 Degradation and Potentiated Cancer ImmunotherapyHuiling Zhou, Bo Hou, Yiming Shan, et al.
Nature Communications|June 16, 2023
Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapyMengxue Zhou, Jiaxin Wang, Jiaxing Pan, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 14, 2024
PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of CancerShunan Zhang, Yi Lai, Jiaxing Pan, et al.
Journal of the American Chemical Society|January 5, 2026
In Situ Transformable Photothermal Targeting Chimeras for Spatiotemporally Controllable Protein Degradation and Combination Immunotherapy for CancerYijing Dang, Bo Hou, Jiaxing Pan, et al.
Nature Communications|June 18, 2026
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancerYi Lai, Shunan Zhang, Jiaxing Pan, et al.
Science Advances|November 15, 2024
Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapyBo Hou, Jiayi Ye, Lujia Huang, et al.
Journal of the American Chemical Society|June 23, 2025
Engineering of Sono-Activatable Immunogels for Immunometabolism Disorder Normalization Therapy of Breast CancerYu Guo, Jiaxing Pan, Junjue Wang, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Advanced Materials (Deerfield Beach, Fla.)|September 16, 2023
Self-Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic CancerJiaxing Pan, Yi Lai, Shunan Zhang, et al.
Advanced Drug Delivery Reviews|June 1, 2025
Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumorsPing Zhang, Jiaxing Pan, Shutong Lin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 7, 2022
Self-Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck CancerYun Zhu, Shunan Zhang, Yi Lai, et al.
Angewandte Chemie (International Ed. in English)|April 26, 2025
De Novo Design of Structure-Tunable Multivalent Targeting Chimeras for Tumor-Targeted PD-L1 Degradation and Potentiated Cancer ImmunotherapyHuiling Zhou, Bo Hou, Yiming Shan, et al.
Nature Communications|June 16, 2023
Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapyMengxue Zhou, Jiaxin Wang, Jiaxing Pan, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 14, 2024
PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of CancerShunan Zhang, Yi Lai, Jiaxing Pan, et al.
Journal of the American Chemical Society|January 5, 2026
In Situ Transformable Photothermal Targeting Chimeras for Spatiotemporally Controllable Protein Degradation and Combination Immunotherapy for CancerYijing Dang, Bo Hou, Jiaxing Pan, et al.
Nature Communications|June 18, 2026
POLY-Senolytic nanoplatform for tumor-specific eradication of senescent tumor cells and mitigation of radiotherapy-induced immune resistance of cancerYi Lai, Shunan Zhang, Jiaxing Pan, et al.
Science Advances|November 15, 2024
Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapyBo Hou, Jiayi Ye, Lujia Huang, et al.
Journal of the American Chemical Society|June 23, 2025
Engineering of Sono-Activatable Immunogels for Immunometabolism Disorder Normalization Therapy of Breast CancerYu Guo, Jiaxing Pan, Junjue Wang, et al.
Pageof 3